Table 3.
Univariate and multivariate analysis of the risk factors of 30-day mortality in patients included in the study.
| Univariate Analysis | ||||
|---|---|---|---|---|
| Variable | Death | |||
| No | Yes | HR (CI 95%) | p-Value | |
| (N = 151) | (N = 65) | |||
| Pre intervention, N | 49 (43%) | 65 (57%) | ||
| Intervention, N | 34 (33.3%) | 68 (66.6%) | 1.38 (0.97–1.95) | 0.072 |
| SARS-CoV-2, N | 9 (20%) | 36 (80%) | 1.74 (1.17–2.59) | 0.006 |
| SAPS3 (median, IQR) | 51 (45–67) | 62 (50–74) | 1.01 (1.00–1.02) | 0.083 |
| Gastrointestinal diseases, N | 17 (56.6%) | 13 (43.3%) | 1.18 (0.85–1.64) | 0.333 |
| Infectious diseases, N | 12 (14.5%) | 22 (16.5%) | 0.83 (0.52–1.32) | 0.432 |
| Blood stream infection source: pulmonary, N | 18 (43.9%) | 23 (56.1%) | 1.39 (1.07–1.80) | 0.036 |
| Organism isolated: P. aeruginosa |
11 (37.9%) | 18 (62.1%) | 1.38 (1.09–1.74) | 0.002 |
| Multivariate analysis | ||||
| OR | CI95% | p-value | ||
| SARS-CoV-2 | 1.54 | (1.02–2.29) | 0.036 | |
| Blood stream infection source: pulmonary | 1.75 | (0.87–3.51) | 0.113 | |
| Organism isolated: P. aeruginosa |
1.26 | (0.56–2.83) | 0.573 | |
HR: Hazard Ratio; OR: Odds Ratio; CI: confidence intervals.